Molecular Mechanism of Asthma
- Status
- WITHDRAWN
- Phase
- NA
Clinical Trials Related to Asthma
Related studies linked through entity extraction aliases.
Inflammation and Corticosteroid Responsiveness in Severe Asthma
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Erythema Toxicum Neonatorum in Newborns and the Development of Asthma
- Status
- COMPLETED
- Phase
- N/A
Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.
- Status
- COMPLETED
- Phase
- PHASE3
Sputum and Plasma Levels of Nociceptin and Substance P in Patients With Asthma, COPD and Chronic Cough
- Status
- UNKNOWN
- Phase
- N/A
Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children
- Status
- UNKNOWN
- Phase
- PHASE4
Computer-Based Decision Support in Managing Asthma in Primary Care
- Status
- COMPLETED
- Phase
- NA
Study of Pulmozyme to Treat Severe Asthma Episodes
- Status
- COMPLETED
- Phase
- PHASE2
Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.
- Status
- COMPLETED
- Phase
- PHASE4
Parent-Youth Teamwork in Pediatric Asthma Management
- Status
- COMPLETED
- Phase
- PHASE2
Multi Breath Nitrogen Washout (MBNW) as a Measure of Small Airway Function in Patients With Respiratory Disease
- Status
- UNKNOWN
- Phase
- N/A
Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)
- Status
- COMPLETED
- Phase
- PHASE3